Amniotic stem cells for cellular cardiomyoplasty: Promises and premises

@article{Walther2009AmnioticSC,
  title={Amniotic stem cells for cellular cardiomyoplasty: Promises and premises},
  author={Guillaume Walther and Jean Gekas and Olivier F. Bertrand},
  journal={Catheterization and Cardiovascular Interventions},
  year={2009},
  volume={73}
}
Cellular cardiomyoplasty is undergoing intensive investigation as a new form of therapy for severely damaged hearts. Among several cell types, mesenchymal stem cells (MSCs) have been proposed as a potential cell source. MSC can be found in adult tissues or in fetal tissues like the umbilical chord blood, amniotic membrane, or amniotic fluid (AF). AF‐MSCs have properties intermediate between embryonic and adult MSC, which make them particularly attractive for cellular regeneration. It has been… 
Compared to the amniotic membrane, Wharton’s jelly may be a more suitable source of mesenchymal stem cells for cardiovascular tissue engineering and clinical regeneration
TLDR
This study highlights that WJ-MSCs could act as a functional substitute of endothelial and interstitial cells, which could serve as an appealing and practical single-cell source for CTE and regenerative therapy.
Amniotic fluid stem cells: an ideal resource for therapeutic application in bone tissue engineering.
TLDR
Amniotic fluid-derived stem cells (AFSCs) represent an interesting model for regenerative medicine, also considering their low immunogenicity and the absence of tumor formation after transplantation in nude mice.
Amniotic Fluid Stem Cell Culture Methods
TLDR
There is compelling evidence that AFSCs can differentiate into various cell types of the three germ layers under the proper culturing conditions, and these features along with the compatibility of AF cells may provide patients with opportunities to have access to their own cells.
New frontiers in regenerative medicine in cardiology: the potential of Wharton's jelly mesenchymal stem cells.
TLDR
The peculiar features of Wharton's jelly stromal cells, as the expression of cardiac-specific transcription factors and immunomodulatory molecules suggest that human umbilical cord may be considered as a reliable alternative source of MSC useful for advanced therapy in cardiac regenerative medicine.
Amniotic fluid stem cells: a promising therapeutic resource for cell-based regenerative therapy.
TLDR
Amniotic fluid -derived stem cells (AFS) are considered a novel resource for cell transplantation therapy, due to their high renewal capacity, the "in vitro" expression of embryonic cell lineage markers, and the ability to differentiate in tissues derived from all the three embryonic layers.
Characteristics of Mesenchymal Stem Cells Derived from Amniotic Membrane: A Potential Candidate for Stem Cell-Based Therapy
TLDR
This chapter analyzed the characteristics of AMSCs in terms of critical points considered for clinical application especially in comparison with MSCs retrieved from other sources.
Immunomodulatory properties of human adult and fetal multipotent mesenchymal stem cells
TLDR
The current understanding of the mechanisms behind the immunomodulatory properties of BM MSCs and F-MSCs is reviewed and an increase in the understanding of MSC suppressor mechanisms will offer insights for prevalent clinical use of these versatile adult stem cells in the near future.
Mesenchymal stromal cells from human perinatal tissues: From biology to cell therapy.
TLDR
Focusing on perinatal tissues to isolate MSCs, this work discusses some of the challenges associated with these cell types concentrating on concepts of isolation and expansion, the comparison with cells derived from other tissue sources, regarding phenotype and differentiation capacity and finally their therapeutic potential.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 32 REFERENCES
Amniotic mesenchymal cells autotransplanted in a porcine model of cardiac ischemia do not differentiate to cardiogenic phenotypes.
  • S. Sartore, Maddalena Lenzi, G. Gerosa
  • Biology, Medicine
    European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
  • 2005
Human Amniotic Mesenchymal Cells Have Some Characteristics of Cardiomyocytes
TLDR
It is reported that human amniotic mesenchymal cells (hAMC), which are multipotent cells derived from fetal mesoderm, may be a suitable cell source for CCM and suggest that hAMC possess some characteristics of cardiomyocytes.
Human amniotic fluid‐derived stem cells have characteristics of multipotent stem cells
TLDR
Observations suggest that HAFFTs are pluripotent stem cells that are less differentiated than BM‐MSCs, and that their gene expression profiles vary with passage number during ex vivo expansion.
Clinical grade expansion of human bone marrow mesenchymal stem cells.
TLDR
This chapter tries to describe the optimal conditions for the successful isolation and ex vivo expansion of human MSCs from BM, to be used in all types of cellular therapeutic approaches.
Clonal Amniotic Fluid-Derived Stem Cells Express Characteristics of Both Mesenchymal and Neural Stem Cells1
TLDR
The results of this study suggest that besides being an easily accessible and expandable source of fetal stem cells, amniotic fluid will provide a promising source of neural progenitor cells that may be used in future cellular therapies for neurodegenerative diseases and nervous system injuries.
Molecular and proteomic characterization of human mesenchymal stem cells derived from amniotic fluid: comparison to bone marrow mesenchymal stem cells.
TLDR
Fetal MSCs isolated from second-trimester amniotic fluid are of embryonic origin, can differentiate under appropriate conditions into cell types derived from all three germ layers, and express the pluripotency marker Oct-4, the human Nanog protein, and the stage-specific embryonic antigen-4 (SSEA-4).
Human amniotic fluid-derived stem cells are rejected after transplantation in the myocardium of normal, ischemic, immuno-suppressed or immuno-deficient rat.
Isolation of amniotic stem cell lines with potential for therapy
TLDR
The isolation of human and rodent amniotic fluid–derived stem (AFS) cells that express embryonic and adult stem cell markers are reported and examples of differentiated cells derived from human AFS cells and displaying specialized functions include neuronal lineage cells secreting the neurotransmitter L-glutamate or expressing G-protein-gated inwardly rectifying potassium channels.
...
1
2
3
4
...